Bluejay Diagnostics
BJDX
3 hedge funds and large institutions have $12.2K invested in Bluejay Diagnostics in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 9 closing their positions.
0.08% more ownership
Funds ownership: 0.03% → 0.11% (+0.08%)
73% less funds holding
Funds holding: 11 → 3 (-8)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
91% less capital invested
Capital invested by funds: $129K → $12.2K (-$117K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.34K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.92K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$19 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$40.5K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$38.8K |
| 3 |
Renaissance Technologies
New York
|
-$17.4K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$6.68K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $9.47K | +$3.34K | +179 | +58% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $2.7K | +$1.92K | +103 | +286% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $19 | +$19 | +1 | New |
|
|
AFM
4
Anson Funds Management
Dallas,
Texas
| – | -$40.5K | -1,596 | Closed |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | -$38.8K | -1,526 | Closed |
|
|
6
Renaissance Technologies
New York
| – | -$17.4K | -685 | Closed |
|
|
TSS
7
Two Sigma Securities
New York
| – | -$6.68K | -263 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$6.63K | -261 | Closed |
|
|
HF
9
HRT Financial
New York
| – | -$5K | -198 | Closed |
|
10
Geode Capital Management
Boston,
Massachusetts
| – | -$2.56K | -101 | Closed |
|
11
Two Sigma Investments
New York
| – | -$1.4K | -55 | Closed |
|
|
JF
12
Jump Financial
Chicago,
Illinois
| – | -$1.32K | -52 | Closed |
|
BJDX Hedge Fund Activity: Q4 2024 in Review
3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q4 2024, worth a combined $12.2K — down 91% from $129K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BJDX and 1 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $3.34K. The largest seller was Anson Funds Management, exiting entirely with an estimated $40.5K sold.
- 3 institutional investors held Bluejay Diagnostics (BJDX) as of Q4 2024, down from 11 in Q3 2024.
- Funds reported $12.2K of Bluejay Diagnostics stock for Q4 2024, down 91% quarter-over-quarter.
- 1 fund opened new Bluejay Diagnostics positions in Q4 2024 and 9 closed out, a net change of -8 holders.
- The largest Bluejay Diagnostics buyer in Q4 2024 was UBS Group, an estimated $3.34K added.
- The largest Bluejay Diagnostics seller in Q4 2024 was Anson Funds Management, an estimated $40.5K sold.
Based on aggregated 13F filings for Q4 2024.